RECEPTOR ANTAGONISTS FOR TREATMENT OF METASTATIC BONE CANCER
摘要
<p>The invention provides methods of treating bone cancer, particularly metastatic bone cancer, by administering an IGF-IR antagonist and/or a PDGFR.alpha. antagonist. The invention also provides antibodies that bind to human PDGFR.alpha. and neutralize activation of the receptor. The invention further provides a methods for neutralizing activation of PDGFR.alpha., and a methods of treating a mammal with a neoplastic disease using the antibodie alone or in combination with other agents.</p>
申请公布号
CA2612449(A1)
申请公布日期
2006.12.28
申请号
CA20062612449
申请日期
2006.06.19
申请人
UNIVERSITY OF WASHINGTON;IMCLONE SYSTEMS INCORPORATED;DREXEL UNIVERSITY COLLEGE OF MEDICINE
发明人
LUDWIG, DALE L.;PLYMATE, STEPHEN R.;FATATIS, ALESSANDRO;HUBER, JIM;LOIZOS, NICK